Krystal Biotech
PA - PittsburghBiotechnology
Focus: Krystal Biotech is a gene therapy specialist focused on dermatological and systemic genetic diseases, headquartered in Pittsburgh with a lean, focused pipeline.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Open Jobs
24+56 this month
Hot — 63 jobs added in 30d
Net +56 (63 new, 7 removed). Aggressive expansion phase.
Should You Work at Krystal Biotech?
AI assessmentKrystal Biotech offers gene therapy expertise and near-term clinical catalysts, but lack of transparency on financials and dependence on Phase 3 success makes this a higher-risk, higher-reward career opportunity suited for specialists willing to bet on pipeline inflection.
Why Work Here
- Gene therapy platform with multiple Phase 3 programs, particularly KB803 (beremagene geperpavec) for dystrophic epidermolysis bullosa offering near-term regulatory catalysts
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Long-Term Follow-up Protocol
Dystrophic Epidermolysis BullosaClinical Trials (1)
NCT04917887Long-Term Follow-up Protocol
N/AHelp build intelligence for Krystal Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.